EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark AMJEVITA was filed as Word mark on 07/29/2016 at the European Union Intellectual Property Office.
It was registered as a trademark on 01/06/2017.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 015706559 |
| Application date | July 29, 2016 |
| Publication date | September 26, 2016 |
| Entry date | January 6, 2017 |
| Expiration date | July 29, 2026 |
Trademark owner
One Amgen Center Drive
91320-1799 Thousand Oaks,
US
91320-1799 Thousand Oaks,
US
Trademark representatives
2Amsterdam Eduard van Beinumstraat 10 3rd Floor
1077 CZ Amsterdam
NL
goods and services
5
Pharmaceutical preparations, including biosimilars; pharmaceutical preparations and substances used for the treatment of bone, joint, intestine, colon, skin, lung, eye, bladder, blood cells, and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of autoimmune and immune system, inflammatory, inflammatory bowel, gastrointestinal, musculoskeletal, dermatological, pulmonary, respiratory, oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, acute disc prolapse, inflammatory bowel disease, crohn's disease, ulcerative colitis, intestinal behçet's disease, chronic pouchitis, small bowel lesions; pharmaceutical preparations and substances used for the treatment of hermansky-pudlak syndrome, psoriasis, psoriasis vulgaris, psoriasis arthropica, plaque psoriasis, hidradenitis suppurativa, interstitial cystitis, sleep apnea, sarcoidosis, retinal vascular disorders, uveitis, choroidal neovascularization, pyoderma gangrenosum, giant cell arteritis, netherton syndrome, anaplastic thyroid cancers, asthma, and refractory asthma
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| November 6, 2023 | Change Representative, Published |
ID: 11015706559